Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects [PDF]
Frontiers in Microbiology, 2018 Carbapenem-resistant Enterobacteriaceae (CRE), a major resistance concern emerging during the last decade because of significantly compromising the efficacy of carbapenem agents, has currently become an important focus of infection control.
Shio-Shin Jean +8 more
doaj +6 more sources
Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections [PDF]
Emerging Infectious Diseases, 2014 We evaluated the number of deaths attributable to carbapenem-resistant Enterobacteriaceae by using studies from around the world published before April 9, 2012.
Matthew E. Falagas +3 more
doaj +4 more sources
Paediatric Enterobacteriaceae infections in hospitalised children in Durban, KwaZulu-Natal
Southern African Journal of Infectious Diseases, 2021 Background: Community-acquired Gram-negative Enterobacteriaceae infections in malnourished and HIV-infected hospitalised children are not well documented and are of concern because of increasing antibiotic resistance and limited available treatment ...
Harshna Krishinchand +3 more
doaj +2 more sources
Therapeutic options for carbapenem-resistant Enterobacteriaceae infections [PDF]
Virulence, 2017 In recent years, carbapenem resistance among Enterobacteriaceae has dramatically increased and represents an important threat to global health. The optimal therapeutic management of carbapenem-resistant Enterobacteriaceae (CRE) infections has not been established, because to date, no clinical trials have been performed with this objective.
Enrico Maria Trecarichi +1 more
exaly +5 more sources
Carbapenem and colistin resistance in children with Enterobacteriaceae infections [PDF]
The Turkish Journal of Pediatrics, 2020 Background. Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. As a reserve agent, colistin has been the drug of choice for the treatment of infections caused by CRE.
Zeliha Haytoğlu +5 more
doaj +3 more sources
Antibiotic resistance pattern of clinical isolates of ESBL strains and determination of enzymatic relationship with clinical specimen type [PDF]
مجله پزشکی دانشگاه علوم پزشکی تبریز, 2020 Background: Differences in clinical isolates may affect the frequency of Extended Spectrum Beta-Lactamase enzymes (ESBLs) in some gram-negative bacteria.
Mahyar Porbaran +2 more
doaj +1 more source
In vitro activity of tigecycline against local clinical isolates of some Enterobacteriaceae
Zagazig Journal of Pharmaceutical Sciences, 2020 Infectious diseases that Enterobacteriaceae cause are spreading on a wide scale. Examples of these infections are gastrointestinal tract infections, meningitis, pneumonia, septicemia, urinary tract infections, and wound infections. Antibiotic resistance
Hadeel Eldeeb +3 more
doaj +1 more source
Colistin Resistance among Enterobacteriaceae Isolated from Clinical Samples in Gaza Strip
Canadian Journal of Infectious Diseases and Medical Microbiology, 2021 Bacterial infections, especially drug-resistant infections, are a major global health issue. The emergence of multidrug-resistant (MDR) strains of Enterobacteriaceae and the lack of new antibiotics have worrisome prospects for all of humanity.
Mohammad Qadi +3 more
doaj +1 more source
Enterobacteriaceae infections in Saudi Arabia: a regression analysis
Electronic Physician, 2019 Background: Carbapenem-resistant Enterobacteriaceae (CRE) are multidrug-resistant microorganisms. Infections caused by these microorganisms have limited treatment options, frequently leading to high mortality rates.
Reham Kaki
doaj +1 more source
BMC Nephrology, 2019 Backgound In recent years we have witnessed an increase in infections due to multidrug-resistant organisms in kidney transplant recipients (KTR). In our setting, we have observed a dramatic increase in infections caused by extended-spectrum betalactamase-
Gemma Sanclemente +9 more
doaj +1 more source